Cargando…
H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice
The risk of secondary infection with SARS-CoV-2 and influenza A virus is becoming a practical problem that must be addressed as the flu season merges with the COVID-19 pandemic. As SARS-CoV-2 and influenza A virus have been found in patients, understanding the in vivo characteristics of the secondar...
Autores principales: | Li, Heng, Zhao, Xin, Zhao, Yurong, Li, Jing, Zheng, Huiwen, Xue, Mengyi, Guo, Lei, Zhou, Jian, Yang, Jinling, Zuo, Yuanyuan, Chen, Yanli, Yang, Zening, Fan, Qiqi, Qin, Li, Shi, Haijing, Liu, Longding |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205102/ https://www.ncbi.nlm.nih.gov/pubmed/34060982 http://dx.doi.org/10.1080/22221751.2021.1938241 |
Ejemplares similares
-
A hSCARB2-transgenic mouse model for Coxsackievirus A16 pathogenesis
por: Chen, Yanli, et al.
Publicado: (2021) -
Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice
por: Muturi, Elishiba, et al.
Publicado: (2022) -
Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease
por: Golden, Joseph W., et al.
Publicado: (2021) -
Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice
por: DeDiego, Marta L., et al.
Publicado: (2008) -
Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)